Nijhawan Pardeep — SEC Form 4 filings
SEC reporting owner CIK 1777962. 44 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 44 filings on record, filed 2024-01-12 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 9 legs across 7 filings — 89,571 shares, $249,914 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 40.
- Largest priced transaction: purchase of 30,000 shares @ $2.22 ($66,696) in Edesa Biotech, Inc., filed 2026-03-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Chief Executive Officer, Director, 10% owner | 44 | 9 legs · 89,571 sh · $249,914 | — | 40 |
Form 4 filings — Nijhawan Pardeep
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 5,714 @ $0 | EDGAR |
| 2026-08-04 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 5,324 @ $0 | EDGAR |
| 2026-07-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 3,378 @ $0 | EDGAR |
| 2026-06-16 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 153,550 @ $5.21 | EDGAR |
| 2026-06-01 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 1,671 @ $0 | EDGAR |
| 2026-05-29 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 96,913 @ $0 | EDGAR |
| 2026-05-01 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 1,159 @ $0 | EDGAR |
| 2026-04-10 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 2,578 @ $0 | EDGAR |
| 2026-03-10 | 4 | Edesa Biotech, Inc. (EDSA) | Purchase (P): 1,000 @ $6.60 | EDGAR |
| 2026-03-06 | 4 | Edesa Biotech, Inc. (EDSA) | Purchase (P): 10,000 @ $3.90 | EDGAR |
| 2026-03-05 | 4 | Edesa Biotech, Inc. (EDSA) | Purchase (P): 10,000 @ $4.26 | EDGAR |
| 2026-03-04 | 4 | Edesa Biotech, Inc. (EDSA) | Purchase (P): 10,000 @ $3.63 | EDGAR |
| 2026-03-03 | 4 | Edesa Biotech, Inc. (EDSA) | Purchase (P): 2,000 @ $2 · Purchase (P): 1,000 @ $2.28 | EDGAR |
| 2026-03-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 82,236 @ $0 | EDGAR |
| 2026-03-02 | 4 | Edesa Biotech, Inc. (EDSA) | Purchase (P): 20,571 @ $1.58 · Grant/award (A): 10,016 @ $0 · Purchase (P): 30,000 @ $2.22 | EDGAR |
| 2026-02-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 11,168 @ $0 | EDGAR |
| 2026-01-05 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 10,444 @ $0 | EDGAR |
| 2025-12-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 8,766 @ $0 | EDGAR |
| 2025-11-06 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 6,968 @ $0 | EDGAR |
| 2025-10-03 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 5,908 @ $0 | EDGAR |
| 2025-09-12 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 5,981 @ $0 | EDGAR |
| 2025-08-04 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 6,802 @ $0 | EDGAR |
| 2025-07-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 7,186 @ $0 | EDGAR |
| 2025-06-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 263,200 @ $0 · Grant/award (A): 7,644 @ $0 | EDGAR |
| 2025-05-06 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 6,392 @ $0 | EDGAR |
| 2025-04-03 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 5,784 @ $0 | EDGAR |
| 2025-03-03 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 6,339 @ $0 | EDGAR |
| 2025-02-14 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 100 (derivative) | EDGAR |
| 2025-02-04 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 8,264 @ $0 | EDGAR |
| 2025-01-06 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 8,476 @ $0 | EDGAR |
| 2024-12-03 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 6,420 @ $0 | EDGAR |
| 2024-11-12 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 4,630 @ $0 | EDGAR |
| 2024-11-01 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 150 (derivative) · Grant/award (A): 326,560 (derivative) | EDGAR |
| 2024-10-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 3,300 @ $0 | EDGAR |
| 2024-09-03 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 3,055 @ $0 | EDGAR |
| 2024-08-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 3,317 @ $0 | EDGAR |
| 2024-07-03 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 4,015 @ $0 | EDGAR |
| 2024-06-04 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 4,785 @ $0 | EDGAR |
| 2024-05-01 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 3,083 @ $0 | EDGAR |
| 2024-04-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 3,253 @ $0 | EDGAR |
| 2024-03-25 | 4 | Edesa Biotech, Inc. (EDSA) jointly with Pardeep Nijhawan Medicine Professional Corp | Purchase (P): 5,000 @ $4 | EDGAR |
| 2024-03-01 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 2,765 @ $0 | EDGAR |
| 2024-02-02 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 2,978 @ $0 | EDGAR |
| 2024-01-12 | 4 | Edesa Biotech, Inc. (EDSA) | Grant/award (A): 2,908 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1777962 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →